Healthcare company Merck & Co. has deployed Reval’s software-as-a-service solution, Finextra reports. The solution will provide support to Merck’s foreign exchange (FX) and interest rate derivatives portfolios.
Reval will help the company bring together all of its processes for exposure management, derivative management and hedge accounting onto a single, integrated workflow. In November 2009, Merck and Schering-Plough merged to form the present healthcare company.
Click here for the story from Finextra.